Home Development Services: Low Solubility Compounds
 

Keywords :   


Development Services: Low Solubility Compounds

2013-03-06 11:27:05| drugdiscoveryonline Downloads

For tackling the bioavailability challenges of BCS (Biopharmaceutical Classification System) class II and IV compounds, proven formulation development, analytical and manufacturing capabilities are available at Patheon’s facilities. A variety of approaches are often needed to improve the bioavailability of low solubility BCS class II and IV compounds. Patheon’s Pharmaceutical Development Services combines biopharmaceutics knowledge, preformulation data, and manufacturing technologies with statistical Design of Experiments to overcome bioavailability challenges.

Tags: services low development compounds

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Xumo teams up with Target to offer Hisense Xumo TVs
05.11KT launches 8K AI-powered IPTV set-top box
05.11Tropical Storm Rafael Graphics
More »